Aprea Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell APRE and other ETFs, options, and stocks.About APRE
Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics. It is involved in the development and commercialization of novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein.
CEOOren Gilad
CEOOren Gilad
Employees8
Employees8
HeadquartersDoylestown, Pennsylvania
HeadquartersDoylestown, Pennsylvania
Founded2002
Founded2002
Employees8
Employees8
APRE Key Statistics
Market cap5.78M
Market cap5.78M
Price-Earnings ratio-0.43
Price-Earnings ratio-0.43
Dividend yield—
Dividend yield—
Average volume91.40K
Average volume91.40K
High today—
High today—
Low today—
Low today—
Open price$1.00
Open price$1.00
Volume0.00
Volume0.00
52 Week high$5.00
52 Week high$5.00
52 Week low$0.90
52 Week low$0.90
Stock Snapshot
The current Aprea Therapeutics(APRE) stock price is $0.92, with a market capitalization of 5.78M. The stock trades at a price-to-earnings (P/E) ratio of -0.43.
During the trading day, Aprea Therapeutics(APRE) stock saw an opening price of $1.00, a peak of —, and a bottom of —.
Trading volume for Aprea Therapeutics(APRE) stock has reached 0, versus its average volume of 91.4K.
Over the past 52 weeks, Aprea Therapeutics(APRE) stock has traded between a high of $5.00 and a low of $0.90.
Over the past 52 weeks, Aprea Therapeutics(APRE) stock has traded between a high of $5.00 and a low of $0.90.
People also own
Based on the portfolios of people who own APRE. This list is generated using Robinhood data, and it’s not a recommendation.